Research programme: reproductive health therapeutics - Pantarhei Biosciences

Drug Profile

Research programme: reproductive health therapeutics - Pantarhei Biosciences

Alternative Names: BLACE; OTE F; Oxytocin/estrogen - Pantarhei Biosciences; Renin angiotensin system suppressors - Pantarhei Biosciences; Testetrol - Pantarhei Biosciences

Latest Information Update: 04 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Pantarhei Bioscience
  • Class Hormonal replacements; Hormones
  • Mechanism of Action ACE inhibitors; Angiogenesis inhibitors; Angiotensin receptor antagonists; Estrogen receptor agonists; Oxytocin receptor agonists; Testosterone replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Female testosterone deficiency; Hypogonadism
  • Research Menopausal syndrome
  • No development reported Male infertility

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for research development in Male-infertility in Netherlands
  • 21 Oct 2015 Pantarhei Biosciences has patents pending for testetrol and BLACE
  • 21 Oct 2015 Early research in Menopausal syndrome in Netherlands (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top